These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia. Tolentino MC; Ferenczi A; Ronen L; Poretsky L Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634 [TBL] [Abstract][Full Text] [Related]
9. Periodontal status in subjects with hyperlipidemia and determination of association between hyperlipidemia and periodontal health: a clinicobiochemical study. Shivakumar T; Patil VA; Desai MH J Contemp Dent Pract; 2013 Sep; 14(5):785-9. PubMed ID: 24685775 [TBL] [Abstract][Full Text] [Related]
10. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Santos RD; Ventura LI; Spósito AC; Schreiber R; Ramires JA; Maranhão RC Cardiovasc Res; 2001 Feb; 49(2):456-65. PubMed ID: 11164856 [TBL] [Abstract][Full Text] [Related]
11. Association of Lipid Profile and Body Mass Index with Periodontal Status in Patients with Dyslipidemia with and without Lipid-lowering Medication: A Cross-sectional Study. Techatanawat S; Komchornrit A Oral Health Prev Dent; 2021 Feb; 19():149-156. PubMed ID: 33600091 [TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance. Jeng JR; Jeng CY; Sheu WH; Lee MM; Huang SH; Shieh SM Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol. Cimminiello C; Vigorelli P; Piliego T; Soncini M; Toschi V; Arpaia G; Perolini S; Bonfardeci C Biomed Pharmacother; 1997; 51(4):164-9. PubMed ID: 9207984 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care. Muñoz MA; Liu W; Delaney JA; Brown E; Mugavero MJ; Mathews WC; Napravnik S; Willig JH; Eron JJ; Hunt PW; Kahn JO; Saag MS; Kitahata MM; Crane HM J Acquir Immune Defic Syndr; 2013 Nov; 64(3):254-60. PubMed ID: 23892238 [TBL] [Abstract][Full Text] [Related]
15. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients. Mussoni L; Mannucci L; Sirtori C; Pazzucconi F; Bonfardeci G; Cimminiello C; Notarbartolo A; Scafidi V; Bittolo Bon G; Alessandrini P; Nenci G; Parise P; Colombo L; Piliego T; Tremoli E Atherosclerosis; 2000 Feb; 148(2):397-406. PubMed ID: 10657576 [TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
17. Serum plasminogen activator inhibitor-1 and tumor necrosis factor-α levels in obesity and periodontal disease. Akman PT; Fentoğlu O; Yılmaz G; Arpak N J Periodontol; 2012 Aug; 83(8):1057-62. PubMed ID: 22141357 [TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study. Jen SL; Chen JW; Lee WL; Wang SP Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117 [TBL] [Abstract][Full Text] [Related]
20. Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy. Lacko AG; Kudchodkar BJ; Loney WW; Clearfield MB; Weis S Clin Chem Lab Med; 1998 Jun; 36(6):389-92. PubMed ID: 9711427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]